Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (311-320 of 333) with videos related to

Pageof 34
Sort By:
Journal of Parkinson'S Disease|December 13, 2021
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialM Judith Peterschmitt, Hidemoto Saiki, Taku Hatano, et al.
Neuro-Oncology|April 3, 2020
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium studyNicole J Ullrich, Sanjay P Prabhu, Alyssa T Reddy, et al.
Annals of Neurology|August 28, 2023
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT TrialElizabeth Martina Bebin, Jurriaan M Peters, Brenda E Porter, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 14, 2022
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissionsMark L Hepokoski, Mazen Odish, Michael T Lam, et al.
Annals of Neurology|October 22, 2020
Correction to: "Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective Multicenter Cohort Study of Imaging Selection"Amrou Sarraj, Ameer E Hassan, James Grotta, et al.
Annals of Clinical and Translational Neurology|May 8, 2024
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosisKaarina Kowalec, Arvid Harder, Casandra Dolovich, et al.
Annals of Neurology|January 10, 2020
Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging SelectionAmrou Sarraj, Ameer E Hassan, James Grotta, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsPaola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Pediatric Neurology|August 14, 2024
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) TrialLaura S Farach, Melissa A Richard, Aynara C Wulsin, et al.
Annals of Neurology|August 7, 2025
Depression Polygenicity and Disease Activity and Disability Worsening in Multiple SclerosisAli Manouchehrinia, Kathryn C Fitzgerald, Amber Salter, et al.
Pageof 34

Showing results (311-320 of 333) with videos related to

Sort By:
Pageof 34
Journal of Parkinson'S Disease|December 13, 2021
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialM Judith Peterschmitt, Hidemoto Saiki, Taku Hatano, et al.
Neuro-Oncology|April 3, 2020
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium studyNicole J Ullrich, Sanjay P Prabhu, Alyssa T Reddy, et al.
Annals of Neurology|August 28, 2023
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT TrialElizabeth Martina Bebin, Jurriaan M Peters, Brenda E Porter, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 14, 2022
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissionsMark L Hepokoski, Mazen Odish, Michael T Lam, et al.
Annals of Neurology|October 22, 2020
Correction to: "Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective Multicenter Cohort Study of Imaging Selection"Amrou Sarraj, Ameer E Hassan, James Grotta, et al.
Annals of Clinical and Translational Neurology|May 8, 2024
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosisKaarina Kowalec, Arvid Harder, Casandra Dolovich, et al.
Annals of Neurology|January 10, 2020
Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging SelectionAmrou Sarraj, Ameer E Hassan, James Grotta, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsPaola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Pediatric Neurology|August 14, 2024
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) TrialLaura S Farach, Melissa A Richard, Aynara C Wulsin, et al.
Annals of Neurology|August 7, 2025
Depression Polygenicity and Disease Activity and Disability Worsening in Multiple SclerosisAli Manouchehrinia, Kathryn C Fitzgerald, Amber Salter, et al.
Pageof 34